Skip to main content

Dr. Miller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Miller's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2007 - 2010
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 2004 - 2007
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2025
  • OK State Medical License
    OK State Medical License 2023 - 2025
  • TX State Medical License
    TX State Medical License 2010 - 2025
  • WA State Medical License
    WA State Medical License 2023 - 2025
  • TN State Medical License
    TN State Medical License 2023 - 2025
  • MS State Medical License
    MS State Medical License 2023 - 2024
  • American Board of Internal Medicine Gastroenterology
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study  
    Felipe Samaniego, Boris Blechacz, Ahmed Kaseb, Bruno P Granwehr, Aung Naing, Issam I Raad, Ethan Miller, Harrys A Torres, Nature

Authored Content

  • Determinants and Prognostic Value of Quality of Life in Patients with Pancreatic Ductal AdenocarcinomaFebruary 2018
  • Determinants and Prognostic Value of Quality of Life in Patients with Pancreatic Ductal AdenocarcinomaFebruary 2018
  • Determinants and Prognostic Value of Quality of Life in Patients with Pancreatic Ductal AdenocarcinomaFebruary 2018

Press Mentions

  • Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment Discontinuation
    Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment DiscontinuationFebruary 12th, 2019

Hospital Affiliations